Apex Biotechnology Corp. develops, manufactures, and markets biotechnology and healthcare products.  The Company's products include Sensorex Blood Glucose Monitoring System and Diabetes Management software (DMS).  Apex markets its products worldwide.

Announcement Of The Resolution Board Of Directors
On Approving The 2025q3 Financial Report

Announcement Of The Board Meeting Date Regarding
The Company'S Consolidated Financial Report For 2025q3

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Apex Biotechnology (1733 TT)

Announcement Of The Resolution Board Of Directors On Approving The 2025q3 Financial Report

Announcement Of The Board Meeting Date Regarding The Company'S Consolidated Financial Report For 2025q3

Announcement Of The Resolution Board Of Directors On Approving The 2025q2 Financial Report

Announcement Of The Board Meeting Date Regarding The Company'S Consolidated Financial Report For 2025q2

Due To The Typhoon, The Cash Dividend Distribution Date Will Be Deferred To The Next Business Day.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)